PLEASANTON, Calif., April 03, 2017 -- Title21 Health Solutions (www.Title21.com), a provider of Enterprise Quality Management Software and Cell Therapy Software solutions to help health science organizations improve quality and patient outcomes announces that it is certified by the Small Business Association (SBA) as a Woman-Owned Small Business (WOSB).
WOSB certification signifies that a company is at least 51% woman-owned and is a small business per the SBA’s requirements. WOSB certification enables Title21 Health Solutions to satisfy WOSB federal contracting requirements and meet the specifications of government agencies, institutions and corporations who work to establish diversity in purchasing and vendor relations.
Title21 Health Solutions is led by Chief Executive Officer and President, Lynn Fischer, and over half of its employees are women. “We are thrilled that Title21 Health Solutions’ official certification as a Woman-Owned Small Business will expand our opportunities and support our customers to an even greater extent by helping them meet their supplier diversity initiatives,” stated Fischer. “I am honored to be at the helm of a progressive and innovative company and among those who can inspire other women to pursue STEM and leadership positions in tech.”
About Title21 Health Solutions
Title21 Health Solutions continues to gain national recognition for its innovative technology that is able to help hospitals, biotechnology, regenerative medicine and other health science organizations improve quality, efficiency and patient safety. Title21’s product line includes web-based quality management solutions and the most comprehensive cellular therapy software available in the market. Learn more about Title21 Health Solutions at www.Title21.com.
Media Contact Haley Roebuck | [email protected]


Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds 



